P2016

3α,21-Dihydroxy-5α-pregnan-20-one

≥95%

• Sinónimos: 21-Hydroxyallopregnanolone, 5α-Pregnane-3α,21-diol-20-one, 5α-THDOC, Allopregnane-3α,21-diol-20-one, Allotetrahydrodeoxycorticosterone
• Fórmula empírica (notación de Hill): C₂₁H₃₄O₃
• Número CAS: 567-02-2
• Peso molecular: 334.49
• NACRES: NA.77
• PubChem Substance ID: 24278624
• UNSPSC Code: 12352200
• EC Number: 209-300-8
• MDL number: MFCD00051144
• Assay: ≥95%
• Form: powder

Propiedades

• Quality Segment: 200
• assay: ≥95%
• form: powder
• SMILES string: [H][C@@]12CC[C@@]3([H])[C@]4([H])CC[C@H](C(=O)CO)[C@@]4(C)CC[C@]3([H])[C@@]1(C)CC[C@@H](O)C2
• InChI: 1S/C21H34O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h13-18,22-23H,3-12H2,1-2H3/t13-,14+,15-,16-,17-,18+,20-,21-/m0/s1
• InChI key: CYKYBWRSLLXBOW-GDYGHMJCSA-N
• Gene Information: human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562) ; rat ... Gabra2(29706)

Descripción

General description

3α21-Dihydroxy-5α-pregnan-20-one (THDOC) is a neurosteroid. It is synthesized in a two-step process from deoxycorticosterone (DOC) via 5α-dihydrodeoxycorticosterone (DHDOC) intermediate with enzymes 5α-reductase and 3α-hydroxysteroid oxidoreductase catalyzing these steps respectively.[1]

Application

3α,21-Dihydroxy-5α-pregnan-20-one (THDOC) has been used:

• as an γ-aminobutyric acid type A receptor (γ-GABAA) agonist in voltage-clamp measurements studies in Xenopus oocytes[2]
• to test its effect on the spike-wave discharges (SWD) finasteride-treated rats[3]
• in electrophysiological studies with dentate granule cells (DGCs) post controlled cortical impact (CCI) -induced brain injury[4]

Biochem/physiol Actions

3α,21-Dihydroxy-5α-pregnan-20-one (THDOC) is a positive allosteric modulator of the γ-aminobutyric acid A receptor (GABA_A).[1] By modulating GABA_A receptor, THDOC allows sustained hyperpolarization and an increase in chloride influx and membrane conductance in neurons.[5] THDOC, thus modulates neuronal excitability.[6] It possesses anxiolytic, anticonvulsant and sedative properties.[1] The levels of THDOC show variation in different physiological states. A low THDOC level in the mensural phase is speculated to play a role in the pathogenesis of catamenial epilepsy (CE) in women.[7] However, elevated levels are reported in depression.[6] THDOC may have an indirect role in the hypothalamic-pituitary–adrenal (HPA) axis activation during acute stress.[5]

Features and Benefits

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Información de seguridad

• Clase de almacenamiento: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)